Disposable Medical Biosensor Monitors Patients Remotely
|
By HospiMedica International staff writers Posted on 28 Jul 2020 |

Image: The LifeSignals LP1250 Remote Monitoring Patch Platform (Photo courtesy of LifeSignals)
A single-use two channel electrocardiogram (ECG) and heart rate biosensor provides up to three days of patient monitoring with remote data access.
The LifeSignals (Fremont, CA, USA) LP1250 Remote Monitoring Patch Platform is a wireless system designed for the continuous collection and monitoring of cardiac data in ambulatory, hospital, home, and healthcare settings. The data is transmitted wirelessly from the LP1250 to a remote secure server for storage and analysis. The monitoring patch can be integrated into clinical workflows, including remote patient monitoring systems, mobile cardiac telemetry systems, and Holter and event monitoring systems.
Features include a proprietary single-chip (LC1100) processor platform that allows secure capture, storage, and transmission of patient data, even in multi-patient hospital environments that produce multiple interferences; up to 72-hour data capture of both two-channel ECG and heart rate data; and a lightweight and splash-proof profile that improve patient comfort and compliance. The LP1250 will be sold worldwide by LifeSignals as a white-labeled device through a network of partnerships from OEMs and telehealth software providers to specialist hospital facilities.
“Healthcare professionals can remotely access patient data via third-party software for the screening and monitoring of common cardiac arrhythmias such atrial fibrillation, enabling rapid treatment decisions, independent of patient location,” said Surendar Magar, co-founder and CEO of LifeSignals. “The interoperable biosensor gives partners access to a ready-to-integrate, multi-parameter medical wearable with a straightforward ecosystem for fast on-boarding.”
Related Links:
LifeSignals
The LifeSignals (Fremont, CA, USA) LP1250 Remote Monitoring Patch Platform is a wireless system designed for the continuous collection and monitoring of cardiac data in ambulatory, hospital, home, and healthcare settings. The data is transmitted wirelessly from the LP1250 to a remote secure server for storage and analysis. The monitoring patch can be integrated into clinical workflows, including remote patient monitoring systems, mobile cardiac telemetry systems, and Holter and event monitoring systems.
Features include a proprietary single-chip (LC1100) processor platform that allows secure capture, storage, and transmission of patient data, even in multi-patient hospital environments that produce multiple interferences; up to 72-hour data capture of both two-channel ECG and heart rate data; and a lightweight and splash-proof profile that improve patient comfort and compliance. The LP1250 will be sold worldwide by LifeSignals as a white-labeled device through a network of partnerships from OEMs and telehealth software providers to specialist hospital facilities.
“Healthcare professionals can remotely access patient data via third-party software for the screening and monitoring of common cardiac arrhythmias such atrial fibrillation, enabling rapid treatment decisions, independent of patient location,” said Surendar Magar, co-founder and CEO of LifeSignals. “The interoperable biosensor gives partners access to a ready-to-integrate, multi-parameter medical wearable with a straightforward ecosystem for fast on-boarding.”
Related Links:
LifeSignals
Latest Critical Care News
- 3D-Printed Bandage to Help Heal Chronic Wounds
- Ultrasound-Activated Nanoagents Kill Superbugs Hiding in Biofilms
- Painless Microneedle Skin Patch Monitors Immune Health

- Smart T-Shirt Uses AI to Enhance Detection of Heart Rhythm Disorders
- Aptamers Enable Real-Time Biomarker Tracking Without Blood Draws
- Specialized Dressing with Sensor Monitors pH Levels in Chronic Wounds
- AI Model Could Help Diagnose Spinal Cord Disease Up To 30 Months Earlier
- 3D-Printed Swallowable Robot Could Perform Gastrointestinal Procedures
- Next-Gen Hydrogel Could Transform Soft Tissue and Organ Repair
- Engineered Cancer Eating Bacteria Consume Tumors from Inside Out
- ‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes
- Smartphone-Linked Catheter Sensor Spots UTIs Sooner Than Lab Cultures
- AI Tool Identifies Trauma Patients Requiring Blood Transfusions Before Reaching Hospital
- New Clinical Guidelines to Reduce Central Line-Associated Bloodstream Infection
- New Inhalable Treatment for TB Lowers Side Effects
- AI Algorithm Improves Antibiotic Decision-Making in Urinary Tract Infection
Channels
Artificial Intelligence
view channelSurgical Techniques
view channel
Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
Small kidney cancers are increasingly detected during routine CT scans performed for other medical evaluations. These early-stage tumors, classified as T1a renal cell carcinoma, are typically treated with... Read more
Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
Drug-resistant focal epilepsy leaves many patients with persistent seizures despite medication, exposing them to injury risk and reduced quality of life. Traditional surgical options are invasive and can... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more







